{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:08:11Z","timestamp":1790824091415,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T00:00:00Z","timestamp":1543968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"medical research project of Sichuan Medical Association","award":["No. 201363"],"award-info":[{"award-number":["No. 201363"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10753-018-0943-z","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T04:42:37Z","timestamp":1543984957000},"page":"884-894","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Schisandrin B Improves the Renal Function of IgA Nephropathy Rats Through Inhibition of the NF-\u03baB Signalling Pathway"],"prefix":"10.1007","volume":"42","author":[{"given":"Jian-Hua","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ru","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Fei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,5]]},"reference":[{"key":"943_CR1","doi-asserted-by":"publisher","first-page":"16001","DOI":"10.1038\/nrdp.2016.1","volume":"2","author":"KN Lai","year":"2016","unstructured":"Lai, K.N., S.C. Tang, F.P. Schena, J. Novak, Y. Tomino, A.B. Fogo, and R.J. Glassock. 2016. IgA nephropathy. Nature Reviews Disease Primers 2: 16001.","journal-title":"Nature Reviews Disease Primers"},{"key":"943_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000108755","volume":"28","author":"Y Xie","year":"2008","unstructured":"Xie, Y., and X. Chen. 2008. Epidemiology, major outcomes, risk factors, prevention and management of chronic kidney disease in China. American Journal of Nephrology 28: 1\u20137.","journal-title":"American Journal of Nephrology"},{"key":"943_CR3","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/S0272-6386(03)00194-X","volume":"41","author":"R Katafuchi","year":"2003","unstructured":"Katafuchi, R., K. Ikeda, T. Mizumasa, H. Tanaka, T. Ando, T. Yanase, K. Masutani, M. Kubo, and S. Fujimi. 2003. Controlled, prospective trial of steroid treatment in IgA nephropathy: A limitation of low-dose prednisolone therapy. American Journal of Kidney Diseases 41: 972\u2013983.","journal-title":"American Journal of Kidney Diseases"},{"key":"943_CR4","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0140-6736(98)03563-6","volume":"353","author":"C Pozzi","year":"1999","unstructured":"Pozzi, C., P.G. Bolasco, G.B. Fogazzi, S. Andrulli, P. Altieri, C. Ponticelli, and F. Locatelli. 1999. Corticosteroids in IgA nephropathy: A randomised controlled trial. Lancet 353: 883\u2013887.","journal-title":"Lancet"},{"key":"943_CR5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1365-2249.1997.tb08322.x","volume":"110","author":"HY Lan","year":"1997","unstructured":"Lan, H.Y., D.J. Paterson-Nikolic, W. Mu, and R.C. Atkins. 1997. Local macrophage proliferation in the pathogenesis of glomerular crescent formation in rat anti-glomerular basement membrane (GBM) glomerulonephritis. Clinical and Experimental Immunology 110: 233\u2013240.","journal-title":"Clinical and Experimental Immunology"},{"key":"943_CR6","doi-asserted-by":"publisher","first-page":"F1218","DOI":"10.1152\/ajprenal.00050.2011","volume":"301","author":"SM Ka","year":"2011","unstructured":"Ka, S.M., T.T. Hsieh, S.H. Lin, S.S. Yang, C.C. Wu, H.K. Sytwu, and A. Chen. 2011. Decoy receptor 3 inhibits renal mononuclear leukocyte infiltration and apoptosis and prevents progression of IgA nephropathy in mice. American Journal of Physiology-Renal Physiology 301: F1218\u2013F1230.","journal-title":"American Journal of Physiology-Renal Physiology"},{"key":"943_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4103\/0971-4065.159303","volume":"26","author":"M Stangou","year":"2016","unstructured":"Stangou, M., C. Bantis, M. Skoularopoulou, L. Korelidou, D. Kouloukouriotou, M. Scina, I.T. Labropoulou, N.M. Kouri, A. Papagianni, and G. Efstratiadis. 2016. Th1, Th2 and Treg\/T17 cytokines in two types of proliferative glomerulonephritis. Indian Journal of Nephrology 26: 159\u2013166.","journal-title":"Indian Journal of Nephrology"},{"key":"943_CR8","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.2147\/DDDT.S137507","volume":"11","author":"Q Chen","year":"2017","unstructured":"Chen, Q., H. Zhang, Y. Cao, Y. Li, S. Sun, J. Zhang, and G. Zhang. 2017. Schisandrin B attenuates CCl4-induced liver fibrosis in rats by regulation of Nrf2-ARE and TGF-\u03b2\/Smad signaling pathways. Drug Design Development and Therapy 11: 2179\u20132191.","journal-title":"Drug Design Development and Therapy"},{"key":"943_CR9","doi-asserted-by":"publisher","unstructured":"Sun, R., R. Zhai, C. Ma, and M. Wei. 2017, 2017. The anti-growth and anti-metastasis effects of Schisandrin B on hepatocarcinoma cells in vitro and in vivo. Biochemical and Biophysical Research Communications. https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.022 .","DOI":"10.1016\/j.bbrc.2017.06.022"},{"key":"943_CR10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.intimp.2017.05.032","volume":"49","author":"Q Lin","year":"2017","unstructured":"Lin, Q., X. Qin, M. Shi, Z. Qin, Y. Meng, Z. Qin, and S. Guo. 2017. Schisandrin B inhibits LPS-induced inflammatory response in human umbilical vein endothelial cells by activating Nrf2. International Immunopharmacology 49: 142\u2013147.","journal-title":"International Immunopharmacology"},{"key":"943_CR11","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1007\/s10753-017-0631-4","volume":"40","author":"W Zhang","year":"2017","unstructured":"Zhang, W., Z. Sun, and F. Meng. 2017. Schisandrin B ameliorates myocardial ischemia\/reperfusion injury through attenuation of endoplasmic reticulum stress-induced apoptosis. Inflammation 40: 1903\u20131911.","journal-title":"Inflammation"},{"key":"943_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028335","volume":"6","author":"Y Xu","year":"2011","unstructured":"Xu, Y., Z. Liu, J. Sun, Q. Pan, F. Sun, Z. Yan, and X. Hu. 2011. Schisandrin B prevents doxorubicin- induced chronic cardiotoxicity and enhances its anticancer activity in vivo. PLoS One 6: e28335.","journal-title":"PLoS One"},{"key":"943_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1023\/A:1019907316129","volume":"238","author":"KM Ko","year":"2002","unstructured":"Ko, K.M., and B.Y. Lam. 2002. Schisandrin B protects against tert-butylhydroperoxide induced cerebral toxicity by enhancing glutathione antioxidant status in mouse brain. Molecular and Cellular Biochemistry 238: 181\u2013186.","journal-title":"Molecular and Cellular Biochemistry"},{"key":"943_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.intimp.2016.03.037","volume":"35","author":"Z Chen","year":"2016","unstructured":"Chen, Z., M. Guo, G. Song, J. Gao, Y. Zhang, Z. Jing, T. Liu, and C. Dong. 2016. Schisandrin B inhibits Th1\/Th17 differentiation and promotes regulatory T cell expansion in mouse lymphocytes. International Immunopharmacology 35: 257\u2013264.","journal-title":"International Immunopharmacology"},{"key":"943_CR15","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/biof.1224","volume":"41","author":"PK Leong","year":"2015","unstructured":"Leong, P.K., and K.M. Ko. 2015. Schisandrin B induces an Nrf2-mediated thioredoxin expression and suppresses the activation of inflammasome in vitro and in vivo. Biofactors 41: 314\u2013323.","journal-title":"Biofactors"},{"key":"943_CR16","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.freeradbiomed.2012.08.006","volume":"53","author":"R Checker","year":"2012","unstructured":"Checker, R., R.S. Patwardhan, D. Sharma, J. Menon, M. Thoh, H.N. Bhilwade, T. Konishi, and S.K. Sandur. 2012. Schisandrin B exhibits anti-inflammatory activity through modulation of the redox-sensitive transcription factors Nrf2 and NF-\u03baB. Free Radical Biology and Medicine 53: 1421\u20131430.","journal-title":"Free Radical Biology and Medicine"},{"key":"943_CR17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.bcp.2011.11.002","volume":"83","author":"EJ Park","year":"2012","unstructured":"Park, E.J., J.N. Chun, S.H. Kim, C.Y. Kim, H.J. Lee, H.K. Kim, J.K. Park, S.W. Lee, I. So, and J.H. Jeon. 2012. Schisandrin B suppresses TGF\u03b21 signaling by inhibiting Smad2\/3 and MAPK pathways. Biochemical Pharmacology 83: 378\u2013384.","journal-title":"Biochemical Pharmacology"},{"key":"943_CR18","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1248\/bpb.31.602","volume":"31","author":"PY Chiu","year":"2008","unstructured":"Chiu, P.Y., H.Y. Leung, and K.M. Ko. 2008. Schisandrin B enhances renal mitochondrial antioxidant status, functional and structural integrity, and protects against gentamicin-induced nephrotoxicity in rats. Biological & Pharmaceutical Bulletin 31: 602\u2013605.","journal-title":"Biological & Pharmaceutical Bulletin"},{"key":"943_CR19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1142\/S0192415X12500425","volume":"40","author":"S Zhu","year":"2012","unstructured":"Zhu, S., Y. Wang, M. Chen, J. Jin, Y. Qiu, M. Huang, and Z. Huang. 2012. Protective effect of schisandrin B against cyclosporine A-induced nephrotoxicity in vitro and in vivo. American Journal of Chinese Medicine 40: 551\u2013566.","journal-title":"American Journal of Chinese Medicine"},{"issue":"1-3","key":"943_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.tox.2011.05.005","volume":"286","author":"Alessandra Stacchiotti","year":"2011","unstructured":"Stacchiotti, A., Volti.G. Li, A. Lavazza, I. Schena, M.F. Aleo, L.F. Rodella, and R. Rezzani. 2011. Different role of Schisandrin B on mercury-induced renal damage in vivo and in vitro. Toxicology 286: 48\u201357.","journal-title":"Toxicology"},{"key":"943_CR21","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1159\/000485346","volume":"42","author":"L Wei","year":"2017","unstructured":"Wei, L., Y. Du, L. Jia, X. Ma, Z. Chen, J. Lu, L. Tian, Z. Duan, F. Dong, Z. Lv, G. Yao, R. Fu, and L. Wang. 2017. Therapeutic effects of FK506 on IgA nephropathy rat. Kidney & Blood Pressure Research 42: 983\u2013998.","journal-title":"Kidney & Blood Pressure Research"},{"key":"943_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00467-010-1703-y","volume":"26","author":"KN Lai","year":"2011","unstructured":"Lai, K.N., L.Y. Chan, H. Guo, S.C. Tang, and J.C. Leung. 2011. Additive effect of PPAR-\u03b3 agonist and ARB in treatment of experimental IgA nephropathy. Pediatric Nephrology 26: 257\u2013266.","journal-title":"Pediatric Nephrology"},{"key":"943_CR23","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.jep.2013.10.038","volume":"150","author":"Y Hu","year":"2013","unstructured":"Hu, Y., Z. Hu, S. Wang, X. Dong, C. Xiao, M. Jiang, A. Lv, W. Zhang, and R. Liu. 2013. Protective effects of Huang-Lian-Jie-Du-Tang and its component group on collagen-induced arthritis in rats. Journal of Ethnopharmacology 150: 1137\u20131144.","journal-title":"Journal of Ethnopharmacology"},{"key":"943_CR24","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1093\/ndt\/gfv017","volume":"30","author":"SN Cox","year":"2015","unstructured":"Cox, S.N., G. Serino, F. Sallustio, A. Blasi, M. Rossini, F. Pesce, and F.P. Schena. 2015. Altered monocyte expression and expansion of non-classical monocyte subset in IgA nephropathy patients. Nephrology Dialysis Transplantation 30: 1122\u20131232.","journal-title":"Nephrology Dialysis Transplantation"},{"key":"943_CR25","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1681\/ASN.V12122636","volume":"12","author":"M Sakatsume","year":"2001","unstructured":"Sakatsume, M., Y. Xie, M. Ueno, H. Obayashi, S. Goto, I. Narita, N. Homma, K. Tasaki, Y. Suzuki, and F. Gejyo. 2001. Human glomerulonephritis accompanied by active cellular infiltrates shows effector T cells in urine. Journal of the American Society of Nephrology 12: 2636\u20132644.","journal-title":"Journal of the American Society of Nephrology"},{"key":"943_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000189285","volume":"74","author":"TH Wu","year":"1996","unstructured":"Wu, T.H., S.C. Wu, T.P. Huang, C.L. Yu, and C.Y. Tsai. 1996. Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Sch\u00f6nlein-Henoch purpura. Nephron 74: 79\u201388.","journal-title":"Nephron"},{"key":"943_CR27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/ndt\/16.2.269","volume":"16","author":"CS Lim","year":"2001","unstructured":"Lim, C.S., S. Zheng, Y.S. Kim, C. Ahn, J.S. Han, S. Kim, J.S. Lee, D.W. Chae, J.R. Koo, R.W. Chun, and J.W. Noh. 2001. Th1\/Th2 predominance and proinflammatory cytokines determine the clinicopathological severity of IgA nephropathy. Nephrology Dialysis Transplantation 16: 269\u2013275.","journal-title":"Nephrology Dialysis Transplantation"},{"key":"943_CR28","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1046\/j.1523-1755.2002.00193.x","volume":"61","author":"J Syrj\u00e4nen","year":"2002","unstructured":"Syrj\u00e4nen, J., M. Hurme, T. Lehtim\u00e4ki, J. Mustonen, and A. Pasternack. 2002. Polymorphism of the cytokine genes and IgA nephropathy. Kidney International 61: 1079\u20131085.","journal-title":"Kidney International"},{"key":"943_CR29","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s00296-012-2624-9","volume":"33","author":"SH Lee","year":"2013","unstructured":"Lee, S.H., E.J. Lee, S.W. Chung, R. Song, J.Y. Moon, S.H. Lee, S.J. Lim, Y.A. Lee, S.J. Hong, and H.I. Yang. 2013. Renal involvement in ankylosing spondylitis: Prevalence, pathology, response to TNF-a blocker. Rheumatology International 33: 1689\u20131692.","journal-title":"Rheumatology International"},{"key":"943_CR30","doi-asserted-by":"publisher","first-page":"F945","DOI":"10.1152\/ajprenal.00423.2007","volume":"294","author":"KN Lai","year":"2008","unstructured":"Lai, K.N., J.C. Leung, L.Y. Chan, M.A. Saleem, P.W. Mathieson, F.M. Lai, and S.C. Tang. 2008. Activation of podocytes by mesangial-derived TNF-alpha: Glomerulo-podocytic communication in IgA nephropathy. American Journal of Physiology-Renal Physiology 294: F945\u2013F955.","journal-title":"American Journal of Physiology-Renal Physiology"},{"key":"943_CR31","doi-asserted-by":"crossref","first-page":"53276","DOI":"10.18632\/oncotarget.18394","volume":"8","author":"Y Guo","year":"2017","unstructured":"Guo, Y., Z. Song, M. Zhou, Y. Yang, Y. Zhao, B. Liu, and X. Zhang. 2017. Infiltrating macrophages in diabetic nephropathy promote podocytes apoptosis via TNF-\u03b1-ROS-p38MAPK pathway. Oncotarget 8: 53276\u201353287.","journal-title":"Oncotarget"},{"key":"943_CR32","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1159\/000108645","volume":"107","author":"L Nee","year":"2007","unstructured":"Nee, L., N. Tuite, M.P. Ryan, and T. McMorrow. 2007. TNF-alpha and IL-1 beta-mediated regulation of MMP-9 and TIMP-1 in human glomerular mesangial cells. Nephron Experimental Nephrology 107: e73\u2013e86.","journal-title":"Nephron Experimental Nephrology"},{"key":"943_CR33","first-page":"141","volume":"151","author":"GH Tesch","year":"1997","unstructured":"Tesch, G.H., H.Y. Lan, R.C. Atkins, and D.J. Nikolic-Paterson. 1997. Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis. American Journal of Pathology 151: 141\u2013150.","journal-title":"American Journal of Pathology"},{"key":"943_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejphar.2012.05.030","volume":"692","author":"KW Zeng","year":"2012","unstructured":"Zeng, K.W., T. Zhang, H. Fu, G.X. Liu, and X.M. Wang. 2012. Schisandrin B exerts anti-neuroinflammatory activity by inhibiting the Toll-like receptor 4-dependent MyD88\/IKK\/NF-\u03baB signaling pathway in lipopolysaccharide-induced microglia. European Journal of Pharmacology 692: 29\u201337.","journal-title":"European Journal of Pharmacology"},{"key":"943_CR35","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s12272-016-0713-0","volume":"39","author":"Z Cai","year":"2016","unstructured":"Cai, Z., J. Liu, H. Bian, J. Cai, and G. Zhu. 2016. Suppression of P2X7\/NF-\u03baB pathways by Schisandrin B contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury. Archives of Pharmacal Research 39: 499\u2013507.","journal-title":"Archives of Pharmacal Research"},{"key":"943_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fnmol.2015.00073","volume":"8","author":"N Kopitar-Jerala","year":"2015","unstructured":"Kopitar-Jerala, N. 2015. Innate immune response in brain, NF-kappa B signaling and cystatins. Frontiers in Molecular Neuroscience 8: 73.","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"943_CR37","doi-asserted-by":"crossref","unstructured":"Park, M.H., and J.T. Hong. 2016. Roles of NF-\u03baB in cancer and inflammatory diseases and their therapeutic approaches. Cells 5(2). pii: E15.","DOI":"10.3390\/cells5020015"},{"key":"943_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/10715762.2011.638291","volume":"46","author":"VV Giridharan","year":"2012","unstructured":"Giridharan, V.V., R.A. Thandavarayan, H.N. Bhilwade, K.M. Ko, K. Watanabe, and T. Konishi. 2012. Schisandrin B, attenuates cisplatin-induced oxidative stress, genotoxicity and neurotoxicity through modulating NF-\u03baB pathway in mice. Free Radical Research 46: 50\u201360.","journal-title":"Free Radical Research"},{"key":"943_CR39","first-page":"598","volume":"70","author":"W Liu","year":"2015","unstructured":"Liu, W., Y. Liu, Z. Wang, T. Yu, Q. Lu, and H. Chen. 2015. Suppression of MAPK and NF-\u03ba B pathways by schisandrin B contributes to attenuation of DSS-induced mice model of inflammatory bowel disease. Pharmazie 70: 598\u2013603.","journal-title":"Pharmazie"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-018-0943-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-018-0943-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-018-0943-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T16:20:11Z","timestamp":1662567611000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-018-0943-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,5]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["943"],"URL":"https:\/\/doi.org\/10.1007\/s10753-018-0943-z","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,5]]},"assertion":[{"value":"5 December 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and Ethical Standards"}},{"value":"All contributing authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The present study was approved by the Animal Care and Use Committee of Southwest Medical University (Luzhou, China), and all procedures performed in the studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}